The estimated Net Worth of Kathleen P. Leneghan is at least $2.54 Million dollars as of 11 March 2022. Ms. Leneghan owns over 20,000 units of Invacare stock worth over $110,066 and over the last 7 years she sold IVC stock worth over $0. In addition, she makes $2,425,160 as Chief Financial Officer and Senior Vice President at Invacare.
Kathleen has made over 2 trades of the Invacare stock since 2018, according to the Form 4 filled with the SEC. Most recently she bought 20,000 units of IVC stock worth $29,800 on 11 March 2022.
The largest trade she's ever made was buying 20,000 units of Invacare stock on 11 March 2022 worth over $29,800. On average, Kathleen trades about 1,767 units every 80 days since 2018. As of 11 March 2022 she still owns at least 166,767 units of Invacare stock.
You can see the complete history of Ms. Leneghan stock trades at the bottom of the page.
Kathleen P. Leneghan serves as Chief Financial Officer, Senior Vice President of the Company. She served as Vice President and Corporate Controller of the company since 2003. Ms. Leneghan has been employed by the company for 28 years, serving in various financial roles in North America and Europe. Prior to joining the Company, Ms. Leneghan was an audit manager with Ernst &Young LLP.
As the Chief Financial Officer and Senior Vice President of Invacare, the total compensation of Kathleen Leneghan at Invacare is $2,425,160. There are 1 executives at Invacare getting paid more, with Matthew Monaghan having the highest compensation of $8,340,920.
Kathleen Leneghan is 56, she's been the Chief Financial Officer and Senior Vice President of Invacare since 2018. There are 10 older and 8 younger executives at Invacare. The oldest executive at Invacare Corp. is Susan Alexander, 63, who is the Independent Director.
Kathleen's mailing address filed with the SEC is ONE INVACARE WAY, , ELYRIA, OH, 44035.
Over the last 21 years, insiders at Invacare have traded over $3,551,958 worth of Invacare stock and bought 391,450 units worth $2,325,949 . The most active insiders traders include Edward F Crawford, Aaron Malachi Iii Mixon, and Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of $10,700. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth $47,900.
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Invacare executives and other stock owners filed with the SEC include: